文献速递细菌感染、耐药与抗菌药物医院感染防控

社区获得性耐甲氧西林金黄色葡萄球菌携带的清除:一项叙述性综述

Eradication of community-onset Methicillin-resistant Staphylococcus aureus carriage: a narrative review.
PubMed 文献 · Clin Microbiol Infect · 2024-01-11

该叙述性综述检索PubMed至2023年7月,总结社区获得性MRSA携带者清除定植策略的证据。仅鼻腔携带者局部治疗有效,鼻用莫匹罗星联合氯己定体浴高效;鼻外定植者加用口服抗生素可能提高成功率,但全身治疗研究异质性高。长期清除在MRSA低流行国家更可能实现,需更多研究确定最佳全身抗菌药物。

要点

  • 仅鼻腔携带者:鼻用莫匹罗星联合氯己定体浴高效。
  • 鼻外定植者:加用口服抗生素可能较单用局部治疗提高成功率。
  • 多数证据支持局部治疗联合利福平及另一种抗菌药物。

核心结论

  • 社区获得性MRSA清除治疗决策应基于治疗目标(医疗环境中短期降低细菌载量 vs. 社区环境中长期清除)与成功清除的可能性。
  • 鼻外长期清除加用全身抗生素联合方案是合理的。
  • 需更多研究确定MRSA清除中最有效的全身抗菌药物。

研究设计与样本

  • 叙述性综述,检索PubMed数据库自建库至2023年7月关于MRSA清除的研究。

主要发现

  • 局部治疗对仅鼻腔携带和暂时降低载量有效。
  • 鼻用莫匹罗星软膏联合氯己定体浴对社区仅鼻腔MRSA携带者高效。
  • 鼻外定植患者加用口服抗生素可能较单用局部治疗提高成功率。
  • 全身治疗鼻外MRSA清除的研究在抗菌药物、疗程和对照组方面异质性高。
  • 益生菌清除治疗是有前景的新型非抗生素策略。

关键数值与推荐

  • 多数证据支持局部治疗联合利福平和另一种抗菌药物。
  • 全身抗生素联合方案对鼻外长期清除是合理的。

临床怎么用

  • 个体患者是否进行社区获得性MRSA清除治疗,应综合治疗目标与成功清除可能性决定。
  • 成功清除可能性受个体治疗失败危险因素和再定植风险影响。
  • 鼻外长期清除可加用全身抗生素联合方案(作者认为合理)。

局限性

  • 社区获得性MRSA携带者个体清除策略有效性的数据匮乏。
  • 全身治疗鼻外MRSA清除的研究在抗菌药物、疗程和对照组方面异质性高。
  • 需更多研究确定MRSA清除中最有效的全身抗菌药物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) colonization increases infection risk in both patients and healthy individuals. Decolonization therapy has been proven to reduce S. aureus infections, but data on the effectiveness of individual decolonization strategies in community-onset MRSA carriage are scarce. OBJECTIVES: The aim of this narrative review was to summarize the evidence on strategies for the elimination of MRSA colonization in community-onset MRSA carriers. SOURCES: PubMed database was searched for studies on MRSA eradication, from inception to July 2023. CONTENT: Topical therapy is proven to be effective in nasal-only carriage and in temporary load reduction. Mupirocin nasal ointment in combination with chlorhexidine body wash is highly effective in nasal-only MRSA carriers in the community as well. In patients with extra-nasal colonization, addition of orally administered antibiotics likely increases success rates compared with topical therapy alone. Studies on systemic treatment of extra-nasal MRSA decolonization are subject to a high heterogeneity of antimicrobial agents, treatment duration, and control groups. The majority of evidence supports the use of a combination of topical therapy with rifampin and another antimicrobial agent. Decolonization treatment with probiotics is a promising novel non-antibiotic strategy. However, achieving long-term decolonization is more likely in countries with low MRSA prevalence, given the risk of recolonization in a context of high MRSA prevalence. IMPLICATIONS: The decision to pursue community-onset MRSA eradication treatment in the individual patient should be based on the combination of the treatment objective (short-term bacterial load reduction in health care settings vs. long-term eradication in community settings), and the likelihood of successful decolonization. The latter is influenced by both individual risk factors for treatment failure, and the risk of recolonization. The addition of a combination of systemic antibiotics is rational for extra-nasal long-term decolonization. To determine the most effective systemic antimicrobial agents in MRSA decolonization, more research is needed.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Westgeest AC, Hanssen JLJ, de Boer MGJ, et al. Eradication of community-onset Methicillin-resistant Staphylococcus aureus carriage: a narrative review. Clin Microbiol Infect. 2024. PMID: 38215977. doi:10.1016/j.cmi.2024.01.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。